News room

Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment

Media contact


Nicklas Westerholm, CEO

Yilmaz Mahshid, CFO


Calendar and upcoming reports

April 6, 2023
Penser Podden

April 26, 2023
Interim report January-March 2023

Show more events



Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10